Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
International Journal of Cancer|July 17, 2007
The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancersElizabeth A Waterman, Neil A Cross, Jenifer M Lippitt, et al.Cancers|April 3, 2021
Osteoblast-Derived Paracrine and Juxtacrine Signals Protect Disseminated Breast Cancer Cells from StressRussell Hughes, Xinyue Chen, Natasha Cowley, et al.Journal of Geriatric Oncology|July 18, 2025
Variation in bone health management in older women with breast cancer: A secondary analysis of the Age Gap studyElisavet Theodoulou, Charlene Martin, Jenna Morgan, et al.Breast Cancer Research : BCR|March 29, 2008
Evaluation of the current knowledge limitations in breast cancer research: a gap analysisAlastair Thompson, Keith Brennan, Angela Cox, et al.Bone|August 18, 2015
Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivoMarie-Therese Haider, Keith D Hunter, Simon P Robinson, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2015
Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancerNing Wang, Freyja Docherty, Hannah K Brown, et al.Journal of Experimental & Clinical Cancer Research : CR|October 21, 2015
The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancerNing Wang, Kimberley J Reeves, Hannah K Brown, et al.Breast Cancer Research : BCR|December 1, 2019
Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenograftsDiane Lefley, Faith Howard, Fawaz Arshad, et al.Oncology Reports|April 6, 2006
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumoursDaniele Santini, Bruno Vincenzi, Rosemary A Hannon, et al.Journal of Cellular and Molecular Medicine|October 13, 2009
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathwayMarta Coscia, Elena Quaglino, Manuela Iezzi, et al.Pageof 9